Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
Julphar
Daiichi Sankyo
Teva
Queensland Health

Generated: July 19, 2019

DrugPatentWatch Database Preview

Litigation Details for McGuire v. Dendreon Corporation (W.D. Wash. 2007)

Try a free trialSee Plans and Pricing

« Back to Dashboard

McGuire v. Dendreon Corporation (W.D. Wash. 2007)

Docket ➤ Sign Up Date Filed 2007-05-24
Court District Court, W.D. Washington Date Terminated
Cause 15:78m(a) Securities Exchange Act Assigned To Marsha J. Pechman
Jury Demand Both Referred To
Parties BOGDAN DZIURZYNSKI; DAVID URDAL; DENDREON CORPORATION; GEORGE GROUP; GREGORY SHIFFMAN; HAILAN HU; HAL SCHONFIELD; JAMES RYE; JOHN MCDEVITT; KENNETH MCGUIRE; LESLIE FREDERICK; MCGUIRE GROUP; MICHAEL JANUS; MITCHELL H GOLD; PARVIZ VALANDANI; PETER MOUNTANOS; REGINA ODIAN; RICHARD HAMM, JR; ROBERT KIRK ODIAN; RONALD COTTON; RUTH KUNATH; THOMAS M. LEVETT; WILLIAM MOUNTANOS
Patents 3,663,607
Attorneys Allison B Waters; Barry M Kaplan; Britton F Davis; Claire Loebs Davis; Clifford A Cantor; Daniel B Scotti; Daniel W Turbow; Douglas W Greene; Drew Derrick Hansen; Inessa Baram-Blackwell; John McMakin Neukom; Jordan Connors; Juli E. Farris; Karl Phillip Barth; Lynn Lincoln Sarko; Malaika M Eaton; Marc M Seltzer; Matthew A Carvalho; McGuire Group; Rebecca A Mitchells; Richard C Yarmuth; Ryan C Kirkpatrick; William B Federman; William P Brewer
Firms Boies Schiller and Flexner; Dreier; Federman & Sherwood; Hagens Berman Sobol Shapiro, LLP WA; McNaul Ebel Nawrot & Helgren PLLC; Susman Godfrey (Wa); Susman Godfrey LLP; Wilson Sonsini Goodrich & Rosati (Palo Alto); Yarmuth Wilsdon Calfo PLLC
Link to Docket External link to docket
Small Molecule Drugs cited in McGuire v. Dendreon Corporation
The small molecule drugs covered by the patent cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for McGuire v. Dendreon Corporation (W.D. Wash. 2007)

Date Filed Document No. Description Snippet Link To Document
2010-01-14 138 $3.70 -1.86% (1.25) 3/21/2007 3,663,607 $3.70 0.00% (1.30) Date: Mar …performed valuations of intangible assets such as patents, trademarks, software, customer lists, work force…alone in a combined patient population of 1,207 patents. In the pooled results analysis, the median TNP…revenue estimates extend to 2015 when Provenge‚Äôs patent expires, and we assume an annual cost in the External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Daiichi Sankyo
McKesson
McKinsey
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.